Clinical–Electrophysiologic Correlations: Overview and Common Patterns

16 Clinical–Electrophysiologic Correlations


Overview and Common Patterns


The value of information gained from electrodiagnostic (EDX) studies relies on correct data collection and, even more importantly, correct data interpretation. Mastering the technical aspects of routine nerve conduction studies (NCSs) and electromyography (EMG) usually can be accomplished within several months to one year. However, if appropriate studies have not been chosen for the particular clinical situation or if interpretation of any of the studies is faulty, accurate data may be of little value. Every study must be individualized based on the differential diagnosis and clinical information. Equally important, subsequent modification often is required as a study proceeds and new information is gathered. It cannot be overemphasized that each study can be properly interpreted only alongside the clinical information. The same nerve conduction and EMG data may have a very different meaning in a different clinical setting.


Recognizing the combined pattern of abnormalities on NCSs (motor, sensory, late responses, repetitive nerve stimulation [RNS]) and needle EMG (spontaneous activity, motor unit potential morphology, recruitment, and activation) is the first step toward achieving an electrophysiologic diagnosis. The pattern of abnormalities usually can mark the underlying pathology as neuropathic, myopathic, or secondary to a neuromuscular junction (NMJ) disorder. Furthermore, in neuropathic lesions, the underlying primary nerve pathophysiology – axonal loss or demyelination – usually can be determined. In addition, it usually is possible to assess the temporal course (hyperacute, acute, subacute, or chronic) and severity of the underlying disorder. Localization of the disorder then is determined from the distribution of abnormalities. In the interpretation of a study, no single piece of information leads to a diagnosis. A final electrodiagnosis can be reached only when the overall pattern of NCS–EMG findings is analyzed and then interpreted in light of the clinical information.



Neuropathic Lesions


Neuropathic lesions result from loss or dysfunction of peripheral nerve fibers, their primary nerve cells, or both. Accordingly, polyneuropathy, plexopathy, radiculopathy, and mononeuropathy all are neuropathic lesions, as are disorders primarily affecting the motor neurons or the dorsal root ganglia. Peripheral nerve lesions may primarily affect the axon, resulting in axonal loss, or the myelin, resulting in demyelination. Both axonal loss and demyelination are neuropathic, although they result in different patterns of findings on NCSs and EMG.



Axonal Loss Lesions


Understanding the pattern of changes that takes place over time (time-related changes) is essential in the interpretation of neuropathic lesions. With an axonal loss lesion, an orderly pattern of abnormalities develops over time on NCSs and EMG (Table 16–1). Immediately after an axonal loss lesion (e.g., partial transection of a nerve), clinical weakness and numbness develop. However, wallerian degeneration of the nerve does not occur until days 3 to 5 for motor fibers and days 6 to 10 for sensory fibers (Figure 16–1). Before that time, distal NCSs remain normal. Thus, when the nerve is both stimulated and recorded distal to the lesion, it can still conduct well despite being effectively disconnected from its proximal segment. After wallerian degeneration occurs, NCSs become abnormal, showing changes consistent with axonal loss: amplitudes decrease, with relative preservation of conduction velocities (CVs) and distal latencies (DLs). Amplitudes for motor studies decline slightly earlier than for sensory nerves; this likely occurs due to failure first at the NMJs. If the largest and fastest axons have also been lost, there may be some slowing of CV and DL, but never into the demyelinating range (i.e., CV <75% of lower limit of normal; DL >130% of upper limit of normal).




On needle EMG, decreased recruitment of motor unit action potentials (MUAPs) occurs in weak muscles immediately with the onset of the lesion. Because some axons and their motor units have been lost, the only way to increase force is to fire the remaining available motor units faster, resulting in a pattern of decreased recruitment. No abnormal spontaneous activity or change in MUAP morphology is seen with the onset of the lesion; those changes take time to develop.


Within the next several weeks, abnormal spontaneous activity (i.e., denervating potentials – fibrillation potentials and positive sharp waves) develops. It is well recognized that the time it takes for denervating potentials to develop depends on the length of nerve between the muscle being studied and the site of the lesion. Consider these examples at both extremes of nerve length:



By extrapolating from these values, one can estimate the time it takes for denervating potentials to develop in other axonal loss lesions of nerves of different lengths.


Finally, in the chronic stages of axonal loss lesions, reinnervation follows denervation, which typically takes several months. Reinnervation results in changes in MUAP morphology. MUAPs become longer in duration, higher in amplitude, and polyphasic, reflecting increased numbers of muscle fibers per motor unit. If reinnervation is successful, months to years later spontaneous activity disappears, leaving only reinnervated MUAPs with decreased recruitment on needle EMG. In addition, motor and sensory amplitudes may improve on NCSs after successful reinnervation.


Thus, by looking at the combination of NCS findings (normal or abnormal), spontaneous activity (present or absent), MUAP morphology (normal or reinnervated), and recruitment (normal or decreased), one can estimate the time course of any neuropathic lesion associated with axonal loss.



Demyelinating Lesions


In pure demyelinating lesions (Figure 16–2), the pattern of abnormalities is different from that of axonal loss lesions, and depends on the degree of demyelination. Myelin is essential to maintain the speed of nerve conduction. Accordingly, demyelination first results in marked slowing of CV, as well as prolongation of DLs and late responses. If demyelination is more severe, frank conduction block occurs, with its clinical correlates of sensory loss and weakness associated with blocking of sensory and motor fibers, respectively. Slowing alone, without conduction block, still allows the nerve action potential to reach its destination, albeit more slowly than normal. Pure slowing therefore does not result in any fixed weakness. On the sensory side, pure slowing may result in depressed or absent reflexes and a perception of altered sensation, but not in fixed numbness.


image

FIGURE 16–2 Demyelination and nerve conduction studies.


Demyelination results in marked slowing of conduction velocity and, if severe enough, conduction block. The underlying axon remains intact, however, and wallerian degeneration does not occur. Nerve conduction parameters vary in demyelination, depending on the site(s) of demyelination. A: Demyelination affecting proximal, intermediate, and distal segments of nerve. This distribution results in conduction velocity slowing, prolonged distal latencies (DLs), prolonged late responses, reduced distal amplitudes, and conduction block between distal and proximal stimulation sites. B: Demyelination affecting only distal nerve segments. This distribution results in prolonged DLs and reduced distal amplitudes, when the nerve is stimulated at the wrist and elbow. Because late responses also travel through the distal segment, they are prolonged as well. Conduction velocities are normal, however, and no conduction block is seen between the usual distal and proximal stimulation sites. If a more distal site can be stimulated (e.g., the palm), then a conduction block pattern may be seen between the more distal stimulation site (palm) and the usual distal stimulation site (wrist). C: Demyelination affecting only proximal nerve segments. In this pattern, DLs, amplitudes, and conduction velocities are normal. The only abnormality on routine studies may be prolongation of late responses. If it is possible to stimulate a very proximal site, a conduction block pattern may be seen between the very proximal stimulation site and the usual proximal stimulation site (elbow).


The presence of conduction block has special importance in patients with demyelination. First, it implies that the clinical deficit (weakness, numbness) is secondary to demyelination and, accordingly, that recovery can occur with remyelination. Second, when present in entrapment neuropathies (e.g., radial neuropathy at the spiral groove, median neuropathy at the carpal tunnel), the finding of conduction block can be used to localize the lesion. Finally, in the evaluation of patients with demyelinating polyneuropathy, the presence of conduction block at non-entrapment sites has additional diagnostic significance because it differentiates acquired from inherited conditions. Conduction block characteristically occurs at non-entrapment sites in acquired demyelinating neuropathies, such as Guillain–Barré syndrome or chronic inflammatory demyelinating polyneuropathy (CIDP), but it is not seen in the various inherited demyelinating neuropathies (e.g., Charcot–Marie–Tooth type I) in which demyelination results only in uniform slowing.


When a demyelinating lesion results in conduction block, clinical numbness and weakness develop acutely. Distal to the conduction block, the nerve continues to conduct normally, although it is effectively disconnected from its proximal segment. Accordingly, distal NCSs remain normal, as in acute axonal loss lesions. However, in contrast to axonal loss lesions, the underlying axon remains intact, and wallerian degeneration never occurs. NCSs remain normal distally. However, if the nerve is stimulated above the lesion, electrophysiologic evidence of focal demyelination (i.e., marked CV slowing, conduction block, or both) will be seen.


Conduction block nearly always means demyelination; however, in one unusual situation, conduction block may be seen in an axonal loss lesion. If, following a transection, nerve conduction studies are performed above and below the lesion during the first several days, before wallerian degeneration has occurred, a conduction block-like pattern will be seen (Figure 16–3). If the studies are repeated after one week, however, the distal nerve will have degenerated and the apparent block will no longer be present. Some refer to this as a pseudo-conduction block.



On needle EMG, recruitment decreases in a demyelinating lesion associated with conduction block because the number of available motor units has been reduced. Because the underlying axon remains intact, however, no wallerian degeneration occurs. Therefore, no denervation or subsequent reinnervation occurs. Reduced recruitment remains the only abnormality on needle EMG in a pure demyelinating lesion with conduction block. In cases in which demyelination results only in slowing, without conduction block, clinical muscle strength and its EMG correlate, recruitment, are normal. Thus, in cases where there is only slowing, without conduction block or any axonal loss, the entire needle EMG remains normal.


Pure demyelinating lesions are uncommon. Most demyelinating lesions have some secondary axonal loss, regardless of whether they are inherited or acquired, associated with conduction block or with slowing alone. Such cases will demonstrate a combination of axonal and demyelinating changes on nerve conduction and needle EMG studies. However, usually it still is possible to determine if the primary underlying pathophysiology is demyelination or axonal loss.



Important Neuropathic Patterns


There are several important neuropathic patterns that each electromyographer must be able to recognize. These patterns vary depending on (1) the time course of the lesion, (2) whether the underlying primary pathology is axonal loss or demyelination, and, if it is demyelination, (3) whether demyelination is associated with conduction block or with CV slowing alone. These patterns are the building blocks that, when analyzed together with the distribution of the abnormalities and the clinical information, allow a final electrodiagnosis to be reached.








Demyelination (Slowing and Conduction Block): Single Proximal Lesion




An isolated proximal demyelinating lesion with focal slowing and conduction block produces an important pattern that, if not recognized, often creates confusion. Because the underlying axon remains intact, wallerian degeneration never occurs. Thus, despite clinical findings of weakness or numbness, distal motor and sensory conductions remain normal. Late responses (i.e., F and H waves) may be abnormal, signifying proximal block and slowing. Motor studies, if performed proximally across the lesion, demonstrate conduction block and focal slowing, the electrophysiologic signs of demyelination. Although they typically are not performed proximally, sensory studies would show similar findings. On needle EMG, the only abnormality is decreased recruitment in weak muscles, reflecting that blocked motor units are no longer available to help generate force. Without axonal loss, denervation and reinnervation never occur. This type of lesion often occurs as the result of an episode of prolonged compression or trauma (e.g., radial neuropathy at the spiral groove). Note that if this pattern is seen and the clinical history indicates that the lesion is less than 4 days old, distinguishing this pattern from a hyperacute axonal loss lesion may be difficult. Both will show “conduction block” at the site of the lesion. A repeat study in 1 week may be necessary to make the differentiation. In a purely demyelinating lesion, no drop in distal amplitude should be seen after 1 week, whereas in an axonal loss lesion, distal and proximal amplitudes will both be low after 1 week.


Aug 31, 2016 | Posted by in NEUROLOGY | Comments Off on Clinical–Electrophysiologic Correlations: Overview and Common Patterns

Full access? Get Clinical Tree

Get Clinical Tree app for offline access